Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Adhesion of ZTlido 1.8% with Exercise and Heat
NCT04150536Phase 1Completed
- Sponsor
- Scilex Holding
- Start
- Jan 2016
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of lidocaine 10% oropharyngeal spray in postherpetic neuralgia (PHN) (3 arms), sponsored by Scilex Holding. Primary endpoints: Peak Plasma Concentration, Area Under the Plasma Concentration-Time Curve from Time 0 to 48 hours and 2 more. Started Jan 2016; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT04150536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150536.